These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks. Sardh E, Harper P, Andersson DE, Floderus Y. Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613 [Abstract] [Full Text] [Related]
26. [Recurrent flaccid paralysis indicative of acute intermittent porphyria in a child]. Dibi A, Aitouamar H, Bentahila A. Arch Pediatr; 2010 Dec; 17(12):1670-2. PubMed ID: 21087844 [Abstract] [Full Text] [Related]
27. Identification and characterization of hydroxymethylbilane synthase mutations causing acute intermittent porphyria: evidence for an ancestral founder of the common G111R mutation. De Siervi A, Rossetti MV, Parera VE, Astrin KH, Aizencang GI, Glass IA, Batlle AM, Desnick RJ. Am J Med Genet; 1999 Oct 08; 86(4):366-75. PubMed ID: 10494093 [Abstract] [Full Text] [Related]
36. Acute porphyrias in the Argentinean population: a review. Parera VE, De Siervi A, Varela L, Rossetti MV, Batlle AM. Cell Mol Biol (Noisy-le-grand); 2003 Jun 08; 49(4):493-500. PubMed ID: 12899439 [Abstract] [Full Text] [Related]
37. [Subclinical acute intermittent porphyria. An uncommon cause of chronic hepatitis]. Pérez Martínez J, Castro Márquez C, Pereira Gallardo S, Jiménez Sáenz M, Herrerías Gutiérrez JM. Gastroenterol Hepatol; 2011 Apr 08; 34(4):262-5. PubMed ID: 21477889 [Abstract] [Full Text] [Related]